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The 50 guanine-N7 cap is the first cotranscriptional
modification of messenger RNA. In Saccharomyces
cerevisiae, the first two steps in capping are cata-
lyzed by the RNA triphosphatase Cet1 and RNA gua-
nylyltransferase Ceg1, which form a complex that is
directly recruited to phosphorylated RNA poly-
merase II (RNAP IIo), primarily via contacts between
RNAP IIo and Ceg1. A 3.0 A˚ crystal structure of
Cet1-Ceg1 revealed a 176 kDaheterotetrameric com-
plex composed of one Cet1 homodimer that asso-
ciates with two Ceg1 molecules via interactions
between the Ceg1 oligonucleotide binding domain
and an extended Cet1 WAQKW amino acid motif.
The WAQKW motif is followed by a flexible linker
that would allow Ceg1 to achieve conformational
changes required for capping while maintaining
interactions with both Cet1 and RNAP IIo. The impact
of mutations as assessed through genetic analysis in
S. cerevisiae is consonant with contacts observed in
the Cet1-Ceg1 structure.
INTRODUCTION
The 50 guanine-N7 cap is essential for all eukaryotic organisms
examined thus far and is the first cotranscriptional modification
of cellular pre-messenger RNA (Jove and Manley, 1982; Ras-
mussen and Lis, 1993; Chiu et al., 2002). A mature mRNA cap
plays several distinct roles during the mRNA life cycle, including
coordination of cotranscriptional pre-mRNA processing, effi-
cient translation, and mRNA decay. The mRNA cap is formed
in stepwise fashion by three essential enzymatic activities. In
the first step, RNA triphosphatase hydrolyzes the 50 triphosphate
end of the nascent transcript, generating a diphosphate-termi-
nated pre-mRNA. In the second step, the diphosphate end of
the nascent transcript is capped with GMP by RNA guanylyl-
transferase. In the last step, (guanine-N7) methyltransferase
transfers a methyl group from S-adenosylmethionine (AdoMet)
to the N7 position of the guanine base to form a mature mRNA
cap (cap 0) (Furuichi and Shatkin, 2000; Shuman, 2001).
CotranscriptionalmRNAcapping is facilitated bydirect recruit-
ment of the capping apparatus to the site of transcription via
interactions with RNA polymerase II (RNAP II) and the phosphor-
ylated carboxy-terminal domain (CTD) of the largest RNAP II216 Structure 18, 216–227, February 10, 2010 ª2010 Elsevier Ltd Allsubunit, Rpb1 (Cho et al., 1997; McCracken et al., 1997; Yue
et al., 1997; Fabrega et al., 2003). The RNAP II CTD consists
of tandem heptad repeats with the consensus sequence
(Y1S2P3T4S5P6S7) (Corden, 1990). The number of repeats varies
among eukaryotes, ranging from 26–27 in Saccharomyces cere-
visiae to 52 repeats in human (Dahmus, 1994). The CTD
undergoes waves of phosphorylation and dephosphorylation at
Ser2, Ser5, and Ser7 positions in coordination with the transcrip-
tion cycle (Phatnani and Greenleaf, 2006; Egloff and Murphy,
2008). In S. cerevisiae, Ser5 phosphorylation occurs first in
linker-proximal regions of the CTD during early elongation in
a process that results in coordinated recruitment of several
factors to the transcriptional complex, including the RNA guany-
lyltransferase (Ceg1) and methyltransferase (Abd1) (Cho et al.,
1997; Ho et al., 1998b). The triphosphatase (Cet1) has not
been shown to directly interact with the CTD, but is presumed
to be recruited to the site of transcription via direct interactions
with Ceg1 (Ho et al., 1998a; Takase et al., 2000). Ser2 phosphor-
ylation predominates in linker-distal regions of the CTD during
later stages of elongation. Whereas the Cet1-Ceg1 capping
apparatus is presumed to dissociate from the transcriptional
complex after elongation, the cap methyltransferase (Abd1)
maintains interactions with the RNAP II CTD throughout elonga-
tion (Schroeder et al., 2000, 2004; Komarnitsky et al., 2000).
S. cerevisiae Cet1 is a member of the divalent cation-depen-
dent triphosphatase family observed in protozoa, eukaryotic
viruses, and fungi (Shuman, 2001; Lima et al., 1999; Gu and
Lima, 2005; Benarroch et al., 2008). The X-ray structure of
Cet1 revealed the location of two independent active sites within
parallel tunnels that are formed by homodimerization of a domain
that includes an eight-stranded antiparallel b barrel (Lima et al.,
1999). In S. cerevisiae and Candida albicans, the triphosphatase
and guanylyltransferase are encoded by distinct genes whose
protein products form a noncovalent complex. In mammals
and plants, the triphosphatase and guanylyltransferase occur
in a single polypeptide and, whereas the guanylyltransferase is
conserved across evolution, the triphosphatase domain is a
metal-independent enzyme that shares structural homology to
the cysteine phosphatase superfamily (Changela et al., 2001;
Takagi et al., 1997; Wen et al., 1998).
RNA guanylyltransferase enzymes are conserved throughout
evolution and contain two domains, a nucleotidyl transferase
(NT) domain conserved in capping enzymes, RNA ligases, and
DNA ligases (Shuman and Lima, 2004), and aC-terminal oligonu-
cleotide binding (OB) domain that is observed in capping
enzymes and several DNA ligases. RNA guanylyltransferase
catalyzes capping in two steps. In the first step, GTP is utilizedrights reserved
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Cet1-Ceg1 Capping Apparatusto transfer GMP to a conserved lysine within the NT domain to
form an enzyme lysyl-GMP adduct. In the second step, the
enzyme binds the diphosphate-terminated pre-mRNA, facili-
tating GMP transfer from the lysyl-GMP adduct to the diphos-
phate-terminated pre-mRNA to form a 50 GpppN cap. The OB
and NT domains undergo large conformational changes to facil-
itate capping. The OB and NT domains must open to bind the
GTP substrate, close to catalyze nucleotidyl transfer to the
enzyme, open to release pyrophosphate and to bind the RNA
substrate, close again to catalyze nucleotidyl transfer to the
RNA, then open again to allow product release (Hakansson
et al., 1997; Shuman and Lima, 2004).
Although individual structures have been determined for each
of the cellular enzymes involved in mRNA capping (Lima et al.,
1999; Fabrega et al., 2003, 2004), the basis for interactions
between these enzymes within an intact eukaryotic capping
apparatus remains unresolved. To determine the structural basis
for interactions between the yeast guanylyltransferase and tri-
phosphatase, and to illuminate how the complex is organized
to facilitate the guanylyltransferase catalytic cycle while it
maintains interactions with RNAP II and the triphosphatase,
we coexpressed, purified, and crystallized the yeast Cet1-Ceg1
(triphosphatase-guanylyltransferase) complex and determined
its structure at a resolution of 3.0 A˚. The structure revealed
a four-subunit organization whereby one Cet1 homodimer asso-
ciates with the OB domains from two Ceg1 molecules through
interactions with an extended Cet1 WAQKW amino acid motif.
The Cet1WAQKWmotif is followed by a flexible linker that would
presumably allow Ceg1 to achieve the requisite conformational
changes required for mRNA capping while maintaining interac-
tions with both Cet1 and RNAP II. We assessed the impact of
mutations at sites of interactions observed in our structure in
cell growth assays through genetic analysis by plasmid shuffle
and in vivo complementation in S. cerevisiae.
RESULTS
Purification and Structure Determination
of the S. cerevisiae Cet1-Ceg1 Complex
A Cet1 polypeptide encompassing amino acids 241–549
suffices for triphosphatase activity in vitro and formRNA capping
in vivo (Lehman et al., 1999). S. cerevisiae triphosphatase Cet1
(241–549; referred to as Cet1 hereinafter) and full-length guany-
lyltransferase (Ceg1 1–459) were coexpressed in Escherichia coli
(Experimental Procedures). Although Ceg1 was the only protein
fused to a His6-Smt3 tag, Cet1 and Ceg1 copurified by metal-
affinity chromatography. After removal of the His6-Smt3 tag by
digestion with the Smt3 protease Ulp1 (Mossessova and Lima,
2000), Ceg1 and Cet1 retained the ability to interact as evi-
denced by coelution during anion-exchange and gel-filtration
chromatography (see Figures S1A and S1B available online).
Cet1-Ceg1 eluted in two peaks during anion-exchange chroma-
tography, and analysis of these peaks revealed that one con-
tained a 2:1 complex between Cet1 and Ceg1 (peak 1) while
the other contained a 2:2 complex (peak 2) (Figure S1C). Crystals
were obtained after a few days for peak fractions containing 2:2
Cet1-Ceg1, whereas those containing 2:1 Cet1-Ceg1 took
weeks to form crystals. Crystals from either preparation were
isomorphous, suggesting that the two contained complexes ofStructure 18, 216similar composition. Based on the time it took to obtain crystals
for the 2:1 complex, and based on our structure of the Cet1-
Ceg1 complex (see below), we infer that the 2:1 complex was
in equilibrium with the 2:2 complex and it was the 2:2 complex
that crystallized. A complete data set was collected from a single
crystal to a resolution of 3 A˚, and experimental phases were
obtained from complete data sets collected from two crystals
that were derivatized with thimerosal for 8 or 16 hr. A complete
data set was obtained from a crystal containing selenomethio-
nine-substituted proteins at 4.3 A˚ resolution (Hendrickson
et al., 1990) (Table 1) and used to confirm positions ofmethionine
in our model.
Native and derivative data sets were initially reduced in space
group P6322 and used to calculate phases. An atomic model for
Ceg1 was manually built into electron density and one Cet1 pro-
tomer was docked into the experimental electron density based
on a model derived from previous Cet1 structures (Lima et al.,
1999). Inspection of experimental electron density revealed
additional electron density consistent with another molecule of
Cet1 that was intertwined with the one that was docked into
the density map (Figures S2A and S2C). To confirm our model
and positions for Cet1 and Ceg1 in the asymmetric unit, a com-
plete data set was collected at a single wavelength from a crystal
containing selenomethionine-substituted proteins (Hendrickson
et al., 1990). An anomalous difference Fourier map revealed
electron density proximal to many of the positions for methionine
side chains, thus confirming our model (Figure S2B).
Assuming static disorder in the lattice, we attempted to refine
a model encompassing one Ceg1 molecule and two overlapping
Cet1 protomers in space group P6322, as well as two Ceg1
molecules and two overlapping Cet1 homodimers in space
groups P321 and P63, but this approach failed to provide an
adequate physical explanation for the two overlapping mole-
cules of Cet1 (see Experimental Procedures; Figure S2). Subse-
quent statistical analysis of the data revealed that Cet1-Ceg1
crystals were perfectly twinned (Padilla and Yeates, 2003), and
analysis of a model in space group P63 provided a physical
explanation of how the complex is twinned in the lattice (see
Experimental Procedures; Figure S3). Native and derivative
data sets were reprocessed in space group P63 and experi-
mental phases were calculated. The resulting experimental elec-
tron density was used to evaluate and rebuild the models for one
Cet1 homodimer and two molecules of Ceg1 in the asymmetric
unit (Figures S2A and S2B). The final model was refined by
applying the twin operator during refinement with tight noncrys-
tallographic symmetry (NCS) restraints for backbone atoms
using REFMAC (Murshudov et al., 1997), resulting in an Rwork
and Rfree of 0.249 and 0.298, respectively (Table 1; Figure S4).
Overall Organization of the Cet1-Ceg1 Complex
and Structure of Cet1
Central to the Cet1-Ceg1 complex is one Cet1 homodimer that is
bordered on each side by a molecule of Ceg1 (Figure 1). The two
Cet1 protomers form an extensive dimer interface that is nearly
identical to that observed in structures of Cet1 alone (Figures
2A and 2B; Lima et al., 1999). Interactions between the respec-
tive Cet1 and Ceg1 protomers primarily involve contacts
between the Ceg1 OB domain and an extended Cet1 element
located near the N terminus of our construct that originates–227, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 217
Table 1. Data and Refinement Statistics
Native Complex Thimerosal (0.5 mM, 16 hr) Thimerosal (0.5 mM, 8 hr) SeMet
Data Collection
Source APS 31ID APS 31ID APS 31ID APS 31ID
Wavelength (A˚) 0.9790 0.9790 0.9790 0.9794
Space group P63 P63 P63 P63
Resolution limits (A˚) 25–3.0 (3.11–3.0) 25–4.0 (4.14–4.0) 25–3.2 (3.31–3.2) 25–4.3 (4.45–4.3)
Unit cell a, b, c (A˚) 166.1, 166.1, 172.4 167.1, 167.1, 172.1 166.3, 166.3, 171.5 167.7, 167.7, 172.7
Number of observations 243,217 144,808 201,843 203,087
Number of reflections 52,300 42,584a 100,451a 36,353a
Redundancy 4.7 (3.0) 3.5 (2.1)a 2.6 (1.6)a 5.6 (4.1)a
Completeness (%) 97.7 (93.9) 93.6 (73.3)a 89.7 (69.7)a 98.6 (97.3)a
Mean I/sI 12.7 (1.9) 9.1 (2.5) 5.1 (1.0) 10.2 (2.7)
Rmerge on I
b 10.0 (46.8) 11.8 (24.2) 14.2 (44.3) 10.8 (39.8)
Cutoff criteria I/sI 0.5 0.5 0.5 0.5
Number of heavy-atom sites 6 6
SHARPc FOM (25–3.2 A˚) (acentric/centric) 0.229/0.254
DMd FOM (25–3.2 A˚) 0.786
Refinement
Resolution limits (A˚) 25–3.0 (3.08–3.0)
Number of reflections (working/test) 48,524/2,465
Completeness 95.2 (81.9)
Twin operator h+k, k, l
Cutoff criteria I/sI 0.0
Complex (residues/atoms) 1,330/10,696
Rcryst
e/Rfree 0.249/0.298 (0.238/0.310)
Bond rmsds
Lengths (A˚)/angles () 0.017/2.37
Data in parentheses indicate the statistics for data in the highest-resolution bin. FOM, figure of merit.
a Single wavelength anomalous diffraction data completeness treats Bijvoe¨t mates independently.
b Rmerge =
P
hkl
P
ijI(hkl)i  < I(hkl) >j/PhklPi < I(hkl)i >.
c SHARP (de La Fortelle and Bricogne, 1997).
d DM (Cowtan, 1994).
e R =
P
hkl jFo(hkl)  Fc(hkl)j/
P
hkl jFo(hkl)j, where Fo and Fc are observed and calculated structure factors, respectively.
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Cet1-Ceg1 Capping Apparatusfrom the distal Cet1 protomer, thus resulting in a swapped
configuration for the respective N termini (Figures 1 and 2).
The yeastRNA triphosphataseCet1 includesa signature tunnel
composed of eight antiparallel b strands which direct several
catalytic amino acid side chains into the tunnel interior (Figures
2C and 2D; Lima et al., 1999). In this previous work, Cet1 was
crystallized in thepresenceof ammoniumsulfate andmanganese
ions. The respective positions of these ligands suggested that
the sulfate ion might mimic the position of the nascent mRNA
g-phosphate because it was observed coordinated by several
basic side chains and the manganese ion, the latter coordinated
by several conserved acidic residues that emanate from the
bottom of the tunnel (Figure 2C; Lima et al., 1999). No additional
density was observed in the present structure adjacent to the
aforementioned active site residues within the tunnel, and thus
we infer that both active sites are devoid of ligands (Figure 2D).
Cet1 amino acids 268–539 adopt similar conformations in the
Cet1-Ceg1 complex when compared to Cet1 structures alone
(Lima et al., 1999), although major differences were observed
with respect to the conformation of Cet1 amino acids 241–261.218 Structure 18, 216–227, February 10, 2010 ª2010 Elsevier Ltd AllIn previously determined Cet1 structures, residues 241–261
adopted an extended conformation across the Cet1 dimer inter-
face forming contacts to both Cet1 protomers (Figure 2A), and
the functional importance of these contacts was highlighted by
a Cet1 construct that contained an N-terminal deletion up to
amino acid 275 which resulted in a catalytically active, albeit
monomeric, form of Cet1 (Lehman et al., 1999). Amino acids
268–275 adopt similar conformations to that observed in pre-
vious Cet1 structures. Cet1 amino acids 261 and 268 exhibited
very weak electron density and were presumed disordered,
whereas amino acids 241–261 adopt a distinctly different confor-
mation within the context of interactions with the Ceg1 OB
domain (Figures 2D and 3). The disordered linker between amino
acids 261 and 268 is consistent with previous studies that
showed this region was highly susceptible to protease digestion
in solution (Lehman et al., 1999).
The Structure of Ceg1 in the Cet1-Ceg1 Complex
The Ceg1 guanylyltransferase molecules in the Cet1-Ceg1
complex adopt similar open conformations with respect to therights reserved
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Figure 1. Structure of the S. cerevisiae Triphosphatase-
Guanylyltransferase Complex
(A) Ribbon representation of the complex between the Cet1 RNA
triphosphatase and Ceg1 guanylyltransferase.
(B) Ninety degree rotation of the model from (A).
(C) Ninety degree rotation of the model from (B).
Cet1 protomers are color-coded magenta and yellow, and
Ceg1 protomers are colored blue. Each molecule is labeled.
The Ceg1 NT and OB domains are denoted. N denotes the
respective positions for each Cet1 N terminus color-coded
magenta or yellow. Yellow and magenta circles indicate the six
disordered amino acids between the Cet1 N-terminal WAQKW
motif and the triphosphatase domain, respectively. Structural
representations were generated using PyMOL (http://pymol.
sourceforge.net).
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Cet1-Ceg1 Capping ApparatusOB and NT domains (Figure 3). Examination of the Ceg1 active
site did not reveal electron density for either substrate (GTP) or
the product lysyl-GMP. Comparison to the only other structure
of a cellular guanylyltransferase (C. albicans guanylyltransferase
Cgt1) shows that the Ceg1 OB domain swings an additional 20
away from the NT domain in comparison to that observed for the
open configuration of Cgt1 (Figure 4; Fabrega et al., 2003). Gua-
nylyltransferase capping enzymes undergo conformational
changes that involve opening and closing of the OB and NTStructure 18, 216–227, Febrdomains to facilitate metal-dependent transfer of
GMP from GTP to the active site lysine in step 1 and
transfer of the GMP to the diphosphate-terminated 50
end of nascent mRNA in step 2 (Shuman and Lima,
2004). Comparison of Ceg1 in the open conformation
to the Chlorella virus guanylyltransferase in the closed
conformation (Hakansson et al., 1997; Hakansson and
Wigley, 1998) illustrates the extent of the conforma-
tional changes and that the Ceg1 OB domain would
be required to rotate 60 to achieve the closed confor-
mation as calculated by Dyndom (Hayward and
Berendsen, 1998).
Each of the Ceg1 OB domains engages Cet1
amino acids 245–261 in a similar manner (Figure 5),
although the two Ceg1 molecules were observed in
distinct orientations with respect to the adjacent
Cet1 dimer (Figure 3). In one Cet1-Ceg1 interface,
the OB domain interacts with Cet1 (2400 A˚2 total
buried surface area), and in this conformation the
majority of buried surface area (1900 A˚2) is derived
from contacts between the OB domain and Cet1
amino acids 245–261 although a few minor contacts
were observed between a Cet1 b strand (aa 368–
472) and the OB domain (Figure 3B). In this configu-
ration the Ceg1 NT domain makes no contacts to
Cet1, and the OB and NT domains appear free to
open and close to facilitate GMP transfer. Similar
contacts were observed in the other Cet1-Ceg1 com-
plex, but in this instance the Ceg1 NT domain makes
a few contacts to Cet1 that would be predicted to
block Ceg1 from closing to promote GMP transfer
(Figure 3A). Because this interface buries only
200 A˚2 of additional total surface area, we believethe Ceg1 NT domain would remain free to swing away from
this contact in solution during capping.
Interactions between Cet1 and the Ceg1 OB Domain
and Functional Analysis In Vivo
Interactions between Cet1 and Ceg1 are dominated by contacts
between Cet1 amino acids 245–261 and the Ceg1 OB-fold
domain which bury 1900 A˚2 of total surface area in the respective
interface (Figures 5A and 5B), and this Cet1 element includes theuary 10, 2010 ª2010 Elsevier Ltd All rights reserved 219
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Figure 2. Comparison of Cet1 Crystallized
Alone or in Complex with Ceg1
(A) Ribbon representation of the Cet1 dimer deter-
mined previously highlighting the conserved tryp-
tophan residues in the WAQKW motif (stick repre-
sentation) near the Cet1 N terminus (PDB ID code
1D8H) denoted by single-letter amino acid code.
(B) Ribbon representation of the Cet1 dimer as
observed in the Cet1-Ceg1 complex highlighting
the swapped configuration of N-terminal WAQKW
motifs with residues in stick representation and
denoted by single-letter amino acid code.
One Cet1 protomer is shown in magenta while
the other is colored yellow. N and C indicate the
amino terminus (amino acid 241) and carboxyl
terminus (amino acid 549), respectively. Yellow
and magenta circles indicate the six disordered
amino acids between the Cet1 N-terminal WAQKW
motif and the triphosphatase domain, respectively.
(C) Ribbon-and-stick representation of the Cet1
active site as observed in PDB ID code 1D8H.
(D) Ribbon-and-stick representation of the Cet1
active site from a protomer of Cet1 in the present
structure.
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Cet1-Ceg1 Capping ApparatusWAQKW amino acid motif which has been shown to be essential
for function in vivo and for Cet1-Ceg1 interaction in vitro
(Ho et al., 1999; Lehman et al., 1999; Takase et al., 2000). The
extended conformation observed for Cet1 amino acids 245–
261 enables many of the Cet1 side chains to interact directly
with the Ceg1 OB surface, which is lined by several aliphatic
side chains (Figure 6A) that are conserved between S. cerevisiae
Ceg1 and C. albicans Cgt1 (Figure 6B).
Cet1 Pro245 and Ile246 pack on top of Trp247, whose side
chain makes van der Waals contacts to Ceg1 Trp337, Leu340,
Leu347, and the aliphatic portion of Glu344. Previous mutational
analysis highlighted the importance of Cet1 Pro245 and Trp247
side chains for function in vivo (Takase et al., 2000), and muta-220 Structure 18, 216–227, February 10, 2010 ª2010 Elsevier Ltd All rights reservedtional studies on theC. albicansCgt1 gua-
nylyltransferase suggested that Trp309,
Leu312, and Leu319 side chains contrib-
uted to Cgt1’s essential functions in vivo
and to CaCet1 binding in vitro (Fabrega
et al., 2003). Cgt1 Trp309, Leu312, and
Leu319 are analogous to Ceg1 Trp337,
Leu340, and Leu347. In the present study,
the importance of contacts between
Cet1 and Ceg1 observed in our structure
was assessed for function in vivo by con-
structing mutant ceg1 alleles and testing
their ability to complement a Dceg1 yeast
strain that expressed full-length Cet1
(CET1(1–549)) or a Dcet1Dceg1 yeast
strain (Hausmann et al., 2001) that con-
tained CET1(241–549), an allele that suf-
fices for growth in vivo and is analogous
to the Cet1 construct used in our crystal
structure (ExperimentalProcedures).Con-
sistent with our previous studies on Cgt1,
strains containing W337H or L347A ceg1alleles exhibited slow-growth phenotypes at elevated tempera-
tures in S. cerevisiae containing (CET1(1–549)) which became
more severe in the strain containing CET1(241–549) (Figures
5C and 5D).
Previous studies on the Cgt1 guanylyltransferase highlighted
the importance of Phe258 and Tyr278 side chains for function
in vivo and for CaCet1 binding in vitro (Fabrega et al., 2003).
The analogous residues in Ceg1 are Ile264 and Tyr284, both of
which form one side of a complementary hydrophobic surface
adjacent to Cet1 Pro245 and Ala248 (Figures 5A, 5B, and 6A).
Consistent with interactions observed in our structure, I264A
and Y284A ceg1 alleles exhibited slow-growth phenotypes in
the S. cerevisiae strain containing CET1(241–549) at elevated
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domain
Figure 3. Two Orientations Observed for
Cet1 with Respect to Ceg1 in the Cet1-
Ceg1 Complex
(A) Ribbon representation of one Cet1-Ceg1
complex with views highlighting the position for
Ceg1 in the complex with respect to Cet1.
(B) Same as (A) but for the other complex between
Cet1 and Ceg1 in the heterotetramer and asym-
metric unit.
Ceg1 molecules are presented in the same orien-
tation in (A) and (B) to highlight the differences in
orientations with respect to Cet1. Each molecule
is color-coded as in Figure 1 with yellow and
magenta circles indicating the six disordered
amino acids between the Cet1 N-terminal
WAQKW motif and the triphosphatase domain,
respectively. NT and OB domains are labeled.
The distance between Cet1 amino acids 261 and
268 is indicated in each panel. The distance
between Cet1 amino acid 510 and Ceg1 amino
acid 41 is indicated in each panel.
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Cet1-Ceg1 Capping Apparatustemperatures (Figure 5D). Two other tyrosine residues in Ceg1
(Tyr281 and Tyr282) were also selected for alanine substitution;
however, these mutations did not result in growth defects in
either strain. These results are consistent with our structure,
because Tyr281 and Try282 were not observed interacting with
Cet1 and were presumed disordered within a loop between
amino acids 265 and 284 (dashed line in Figures 5A and 5B).
These results are also consistent with previous genetic and
biochemical studies which suggested that individual alanine
substitutions for analogous positions in Cgt1 (Tyr275 and
Leu276) resulted in no detectable growth defects in vivo or for
CaCet1 binding in vitro (Fabrega et al., 2003).
Previous mutational analysis within the conserved Cet1
WAQKW motif, namely K250A-W251A, resulted in loss of Cet1-
Ceg1 interaction in vitro and elicited a temperature-sensitive
growth phenotype in vivo that could be suppressed by overex-
pression of Ceg1 (Lehman et al., 1999). Cet1 amino acids
Ala248, Gln249, Lys250, and Trp251 establish van der Waals
and electrostatic contacts to Ceg1 side-chain and main-chain
atoms from residues 345–350. In addition, this region of Cet1
contacts Ceg1 amino acid side chains in a helical-loop (HL)
insertion that is not conservedwith theC. albicans guanylyltrans-
ferase Cgt1 (Figure 6B). The remaining amino acid residues of
the Cet1 N-terminal element make additional albeit less exten-
sive contacts to Ceg1 residues Asp370, Asp371, and Leu373
(Figure 6A). The point mutations F308A, Q310A, and F312A or
a mutant allele that deleted the HL insertion (D304–323 or DHL)
exhibited no growth defects in the strain expressing full-length
Cet1 (Figure 5C); however, introduction of these alleles into the
strain containing CET1(241–549) revealed that F312A did not
suffice for growth, as no colonies were obtained on media con-
taining 0.75 mg/ml 5-fluoroorotic acid (5-FOA) after 10 days at
30C or 37C, and only small pinpoint colonies were obtained
after 10 days at 23C (not shown). Although strains containing
F308A or D304–323 alleles were viable, both exhibited tempera-
ture-sensitive growth defects at 23C or 37C (Figure 5D). These
genetic data are consistent with contacts observed in our struc-
ture and with previous studies that support an essential role for
interactions between the Cet1 WAQKW motif and the Ceg1 OBStructure 18, 216domain (Cho et al., 1998; Takase et al., 2000; Hausmann et al.,
2001; Fabrega et al., 2003).
DISCUSSION
The structure determination of a complex between Cet1 and
Ceg1 revealed the architecture of a four-subunit capping appa-
ratus between one Cet1 homodimer and two Ceg1 protomers.
Although our structure revealed a 2:2 Cet1:Ceg1 complex, we
believe that a functional capping apparatus may also contain
only one copy of Ceg1, as evidenced by our ability to isolate
a 2:1 Cet1:Ceg1 complex (see above; Figure S1) and because
two copies of each enzyme are not required for function
in vivo, as a fusion between a monomeric form of Cet1 and the
guanylyltransferase domain of the mouse capping enzyme can
complement a Dceg1Dcet1 strain (Lehman et al., 1999).
Recruitment of capping activities to RNAP II appears
conserved across evolution and includes direct interactions
between the mRNA guanylyltransferase and phosphorylated
RNAP II CTD (Cho et al., 1997; McCracken et al., 1997; Yue
et al., 1997; Ho et al., 1998b; Ho and Shuman, 1999; Fabrega
et al., 2003). In contrast, evolution employs a wide variety of
mechanisms to recruit triphosphatase enzymes to the site of
transcription. In mammals and plants, polypeptides that encode
triphosphatase activity are fused to their respective guanylyl-
transferase via a flexible linker (Ho et al., 1999), thus recruiting tri-
phosphatase activities to RNAP II through covalent association
with the guanylyltransferase (Takagi et al., 1997; Yue et al.,
1997). In the case of the fission yeast Schizosaccharomyces
pombe, the triphosphatase Pct1 binds the phosphorylated
RNAP II CTD directly and does not interact with the guanylyl-
transferase enzyme Pce1 in vitro, suggesting that Pct1 is
recruited to RNAP II independent of Pce1 (Pei et al., 2001; Takagi
et al., 2002). S. cerevisiae andC. albicans share many similarities
with respect to their capping enzymes including noncovalent
interactions between the triphosphatase and the guanylyltrans-
ferase OB domain that are required for cell viability and presum-
ably for recruitment of the triphosphatase to RNAP II under
normal expression conditions (Cho et al., 1998; Hausmann–227, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 221
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Figure 4. Comparison between Ceg1 and Cgt1
(A) Ribbon representations of S. cerevisiae Ceg1 (slate) and C. albicans Cgt1 (red).
(B) Orthogonal view to (A).
Ceg1 and Cgt1 were aligned based on their NT domains, highlighting the conformational differences observed for their respective OB domains. The phosphor-
ylated CTD peptide in the Cgt1 structure is colored yellow in stick representation. The Cet1 N-terminalWAQKWmotif is colored inmagenta in stick representation
in the Ceg1 structure. Domains and polypeptides are labeled.
Structure
Cet1-Ceg1 Capping Apparatuset al., 2001; Takase et al., 2000; Fabrega et al., 2003), although
alternative mechanisms also exist. For instance, a form of Cet1
(D1–264) that no longer interacts with Ceg1 can still be observed
at the 50 ends of genes, but only when Ceg1 is substituted with
the mouse guanylyltransferase (Takase et al., 2000). In addition,
the C. albicans triphosphatase has been shown to directly
interact with the phosphorylated RNAP II CTD (Takagi et al.,
2002). Whereas noncovalent interactions between Cet1 and
Ceg1 likely serve as the primary mechanism to recruit Cet1 to
the site of transcription, these data suggest that Cet1 retains
some ability to interact with RNAP II in the absence of contacts
to Ceg1.
During capping, the guanylyltransferase undergoes large con-
formational changes to bind substrates, catalyze GMP transfer,
and release products. The structure of the Cet1-Ceg1 complex222 Structure 18, 216–227, February 10, 2010 ª2010 Elsevier Ltd Allprovides a model for how this might occur. In our previous
studies with the C. albicans Cgt1 guanylyltransferase, we
showed that interactions between the guanylyltransferase and
the phosphorylated RNAP II CTD were mediated exclusively
through contacts to the guanylyltransferase NT domain (Fab-
rega et al., 2003). In the present study, our structure revealed
a flexible tether between the Cet1 triphosphatase domain and
the Cet1 WAQKW motif which interacts directly with the Ceg1
OB domain. If Ceg1 and Cgt1 utilize a similar surface to interact
with the RNAP II CTD, the resulting model suggests that the
Ceg1 NT domain could associate with the RNAP II CTD while the
OB domain mediates interactions with the Cet1 WAQKW motif
(Figure 7). Furthermore, the flexibility associated with the RNAP
IIo CTD coupled with the flexible tether between the Cet1 tri-
phosphatase domain, WAQKW motif, and OB domain wouldrights reserved
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Figure 5. Structural and Mutational Analysis of the Interface between Cet1 and Ceg1
(A) Interactions between the Cet1 WAQKW motif and the Ceg1 OB domain. The OB domain is depicted in ribbon representation with side chains selected for
mutational analysis colored yellow in stick representation. The helix-loop insertion in Ceg1 is indicated by a bar and the designation HL. The Cet1 N-terminal
element is shown in stick representation in magenta and labeled. Side chains are labeled in black for Ceg1 and magenta for Cet1.
(B) Similar to (A) but with Ceg1 depicted in surface view to highlight the deep canyon in which the Cet1 polypeptide binds. Selected Ceg1 amino acids (yellow) are
labeled.
(C and D) Serial dilutions of S. cerevisiae strains bearing indicated CEG1 alleles (top position at OD600 = 0.5 with three serially diluted concentrations along the
vertical axis). The top of each panel indicates the CET1 strain utilized in each analysis, and individual amino acid substitutions are indicated at the bottom of the
panel. (C) shows results of a complementation assay in a strain expressing full-length CET1(1–549) and (D) shows results of a complementation assay in a strain
expressing CET1(241–549). This latter strain contains a fragment of Cet1 that is analogous to the Cet1 domain determined in the structure of the Cet1-Ceg1
complex.
Structure
Cet1-Ceg1 Capping Apparatusallow the Ceg1 OB and NT domains to undergo the conforma-
tional changes necessary for capping without requiring major
structural rearrangements or Ceg1 dissociation from either
Cet1 or RNAP II. This would not hold true if either Cet1 or
RNAP II interacted with both the NT and OB domains of Ceg1.
Although our structure provides additional details with respect
to the organization of the Cet1-Ceg1 capping apparatus and
a plausible model for its interactions with RNAP II, further work
is required to fully understand how RNAP II interacts with an
intact capping apparatus to facilitate delivery of RNA substrates
to the respective active sites during mRNA capping.Structure 18, 216EXPERIMENTAL PROCEDURES
Production and Purification of the Cet1-Ceg1 Complexes
S. cerevisiae RNA triphosphatase, CET1(241–549), and RNA guanylyltransfer-
ase CEG1 were amplified from genomic DNA obtained from a haploid W303-
1A strain. CET1(241–549) was cloned into pET29b (Novagen), placing an ATG
start codon at position 240. This plasmid was named pET29b-ScCet1(241–
549). Full-length S. cerevisiae RNA guanylyltransferase, CEG1, was cloned
into a pSMT3 TOPO vector (Mossessova and Lima, 2000; Invitrogen) prior to
subcloning the His6Smt3-ScCeg1 reading frame into pET15b to generate
pET15b-Smt3ScCeg1. The vectors pET29b-ScCet1(241–549) and pET15b-
Smt3ScCeg1 were cotransformed into E. coli BL21 (DE3) CodonPlus RIL
(Novagen). A 10 l culture was grown by fermentation at 37C to an A600 of 3–227, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 223
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Figure 6. Stereo Diagram of the Cet1-Ceg1 Complex and Structure-Based Sequence Alignment for Ceg1 and Cgt1
(A) Stick representation of the Ceg1 OB domain with side chains targeted by mutagenesis colored yellow and labeled in black. Cet1 amino acids are labeled and
colored in magenta. The helix-loop insertion is indicated by a black bar and the designation HL.
(B) Sequence alignment for theOBdomains fromCeg1 andCgt1 with secondary structure elements indicated above or below the respective sequence. Residues
targeted for mutational analysis are indicated by black triangles. Residues highlighted in red belong to a hydrophobic cluster that is shared between Ceg1 and
Cgt1, while residues highlighted in green are located in the unique Ceg1 HL insertion that contacts Cet1. Disordered regions in our structure are indicated by
a dashed line.
Structure
Cet1-Ceg1 Capping Apparatusbefore 1 mM IPTG induction for 4 hr at 25C. Cells were harvested by centri-
fugation, suspended in 50 mM Tris-HCl (pH 8.0), 20% sucrose, 500 mM
NaCl, 20 mM imidazole, 0.1% IGEPAL, 1 mM PMSF, 1 mM b-mercaptoetha-
nol, and 10 mg/ml DNase, and sonicated, and insoluble material was removed
by centrifugation. His6Smt3-Ceg1 was purified by metal-affinity chromatog-
raphy (QIAGEN Ni-NTA Superflow resin) and Cet1 was copurified via interac-
tion with Ceg1. The His6-Smt3 tag was removed by Ulp1 proteolysis on ice for
1 hr (Mossessova and Lima, 2000), and the complex was purified by gel-filtra-
tion and anion-exchange chromatography (Superdex200 and MonoQ; Phar-
macia). Two distinct species containing both Cet1 and Ceg1 polypeptides
were separated through both purification steps. Gel-filtration profiles and
SDS-PAGE analysis indicated that one was composed of two molecules of
Cet1 and Ceg1, and the other was composed of two molecules of Cet1 and
one molecule of Ceg1. Approximately 10 mg was obtained for each complex
per liter of E. coli fermentation culture as estimated by the Bradford assay (Bio-
Rad). Both complexes were concentrated to 10 mg/ml in 50 mM NaCl, 10 mM
Tris-HCl (pH 8.0), 1 mM DTT. Aliquots were flash-frozen in liquid nitrogen and
stored at –80C.
To produce selenomethionine-labeled protein, pET29b-ScCet1(241–549)
and pET15b-Smt3ScCeg1 were cotransformed into E. coli B834 (Novagen)
and grown in minimal media containing selenomethionine (Hendrickson
et al., 1990). Cells grew at 37C until cell density reached an A600 of 2.0.
Temperature was reduced to 30C and the culture was adjusted to 1 mM
IPTG to induce protein expression. After 6 hr, cells were harvested and stored224 Structure 18, 216–227, February 10, 2010 ª2010 Elsevier Ltd Allat –80C. The Cet1-Ceg1 protein obtained from these cultures was purified
and crystallized as described for the native protein.Crystallographic Analysis
The Cet1-Ceg1 complex was crystallized by hanging-drop vapor diffusion
against a well solution that contained 1.0 M ammonium citrate, 0.1 M sodium
citrate (pH 5.6), and 1.0% PEG (polyethylene glycerol) 4000 at 18C. Large
crystals (>300 mM) were transferred to a solution containing well solution
and 24% xylitol, incubated in this solution at 4C overnight, and flash-cooled
in liquid nitrogen. To obtain mercury derivatives, crystals were placed into
solutions that contained crystallization media and 0.5 mM thimerosal at 4C
for 8 or 16 hr. Crystals were cryoprotected and frozen as above. A complete
data set was collected from native and mercury-derivatized crystals at the
Advanced Photon Source, SGX-CAT beamline (Argonne National Laboratory,
Argonne, IL, USA). Diffraction intensities were processed with DENZO and
reduced using SCALEPACK (Otwinowski and Minor, 1997) and CCP4
(CCP4, 1994). SHARP was used to calculate phases to 3.2 A˚ (de La Fortelle
and Bricogne, 1997). A model for the Cet1 dimer and its twin mate was gener-
ated by manually docking two Cet1 dimers into the electron density based on
previous structures of Cet1 (Lima et al., 1999). The OB and NT domains from
C. albicans Cgt1 were used as a starting point for building the Ceg1 structure,
using theOprogram (Jones et al., 1991) to buildmissing segments in Ceg1 and
Cet1.rights reserved
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Figure 7. Model for the Organization of the Cet1-Ceg1 Capping Apparatus
On the left is a schematic of the Cet1-Ceg1 complex with one Cet1 protomer shown bound to the phosphorylated RNAP IIo CTD via the NT domain in the open
configuration ready to bind substrates or release products. Interactions between the Ceg1 OB domain and one Cet1 protomer WAQKW motif are followed by
a flexible linker that tethers the Ceg1OBdomain to the Cet1 triphosphatase. On the right is a schematic of the Cet1-Ceg1 complexwith Ceg1 in the closed config-
uration illustrating that Ceg1 can undergo the conformational changes required for capping while maintaining interactions with Cet1 and the phosphorylated
RNAP IIo CTD.
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Cet1-Ceg1 Capping ApparatusA physical model for twinning emanates from analysis of the quaternary
structure in the lattice as it is arranged as a trimer of Cet1-Ceg1 heterodimers
which form a ring-like structure (Figure S3). The plane of the ring is perpendic-
ular to the six-fold axis and, although the real space group is P63, the two-fold
twinning operator (h+k, k,l) is perpendicular to the six-fold axis and makes
the data appear consistent with P6322. Experimental phases determined in
P63 revealed one orientation for each of the two Ceg1 molecules and two
nearly orthogonal orientations for the Cet1 homodimer in the asymmetric
unit (Figures S2 and S3). Because the twinning operator flips the pseudohexa-
meric ring upside down, the structure and its twin mate align with perfect
superposition of the respective Ceg1 molecules (thus the reason for observing
density for Ceg1 in only one position) and two orientations for Cet1 that corre-
spond to the two distinct positions observed in the experimental electron
density for the Cet1 dimer (Figure S2). Although a 1:1 complex between
Cet1 and Ceg1 is also possible in P6322, differences were observed for
Cet1 amino acids 436–450 that break symmetry and suggest that the correct
space group includes a heterotetramer in the asymmetric unit. Further corrob-
orative evidence that P63 was the most probable space group was the obser-
vation that molecular replacement trials using Phaser (McCoy et al., 2007)
generated clear rotational and translational solutions in P6322, but packing
failed unless we allowed backbone clashes. On the other hand, molecular
replacement in P63 generated clear solutions without steric consequences.
The final scheme utilized tight NCS restraints for backbone atoms and
loose NCS restraints for side-chain atoms and by applying the twin operator
(h+k, k, l) during refinement in REFMAC (Murshudov et al., 1997). The final
Rwork and Rfree values were 0.249 and 0.298, respectively. The model exhibits
reasonable geometry for this resolution with 65.3% of residues in most
favored, 30.6% of residues in additional allowed, 4.1% of residues in gener-
ously allowed, and no residues in disallowed regions of Ramachandran space,
values that fall within accepted parameters at this resolution as determined by
PROCHECK (Laskowski et al., 1993). Refinement required manual adjust-
ments in the weighting scheme for geometry and X-ray terms, resulting in
slightly higher than expected root-mean-square deviations (rmsds) in bond
length (0.017 A˚); however, random inspection of several recently determined
high-resolution structures (1.1–1.25 A˚; Protein Data Bank [PDB] ID codes
3A9J, 3HS4, 3KOM, 3KHF, 3FBW, and 3HZA) refined using REFMAC, PhenixStructure 18, 216(Afonine et al., 2005), and SHELX (Sheldrick, 2008) revealed values for rmsds in
bond lengths between 0.010 and 0.017 A˚. A composite simulated annealing
omit map is shown covering several regions of our model (Figure S4).
As an alternative to twinning, we attempted to refine the Cet1-Ceg1 model
assuming that both Cet1 homodimers were superimposed because of static
disorder in the lattice. This was initiated by modeling two Ceg1 chains at full
occupancy and the two conformations of the Cet1 homodimer by four chains
(A and B, A0 and B0) with each chain at half occupancy. Because A and B0 as
well as B and A0 overlap (Figures S2A, S2B, and S3C), refinement of the six
chains was enabled by turning off repulsive forces between the overlapping
Cet1 molecules in CNS (Brunger et al., 1998). The structure was refined using
NCS restraints and harmonic backbone restraints for regions of helical or
b secondary structure at 3.0 A˚ using the twinned data to an Rwork and Rfree
of 0.275 and 0.337, respectively. However, this model, and the statistical anal-
ysis which indicated that the data were perfectly twinned, failed to provide
a physical explanation for the two overlapping Cet1 protomers.
Mutagenesis and Yeast Growth Assays
The plasmid pGYCE-358 contained the CEG1 reading frame under the control
of the CEG1 endogenous promoter (Schwer and Shuman, 1994). Mutations to
replace solvent-exposed hydrophobic residues in the Ceg1 OB-fold domain
and residues in contact with Cet1 were generated by PCR. A deletion mutant
was generated for Ceg1 that removed a helix and loop (D304–323) observed in
interactions with Cet1. Plasmids containing CEG1 mutations were pGYCE-
358-I264A, pGYCE-358-Y281A, pGYCE-358-Y282A, pGYCE-358-Y284A,
pGYCE-358-F308A, pGYCE-358-Q310A, pGYCE-358-F312A, pGYCE-358-
W337H, and pGYCE-358-L347A. The plasmid encoding the internal deletion
in CEG1 was pGYCE-358-D304-323. The effects of mutations on cell growth
were tested by transforming respective pGYCE-358 plasmids into the S. cer-
evisiae strain YBS2 (MATa, leu2, lys2, trp1, ceg1::hisG, pGYCE-360) where
ceg1D is complemented by the CEN URA3 shuffling plasmid pGYCE-360
that contained wild-type CEG1 under control of its endogenous promoter.
The plasmid pRS412-CET1(241–549) was constructed by amplifying the
CET1(241–549) fragment by PCR from genomic DNA of the S. cerevisiae strain
W303-1A. The CET1(241–549) fragment was flanked by the endogenous 50
(520 bp) and 30 (530 bp) UTR elements located adjacent to the CET1 coding–227, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 225
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Cet1-Ceg1 Capping Apparatusregion. The effects for respective mutant alleles on cell growth were tested by
cotransforming respective pGYCE-358 and pRS412-CET1(241–539) plasmids
into theS. cerevisiae strain YBS50 (MATa, leu2, ade2, trp1, his3, ura3, can1 ce-
g1::hisG, cet1::LEU2, p360-CET1/CEG1) in which cet1Dceg1D was comple-
mented by the CEN URA3 plasmid p360-CET1/CEG1 that contained wild-
type CET1 and CEG1 (Hausmann et al., 2001).
Strains were grown on agar plates containing synthetic medium lacking
either tryptophan or tryptophan and adenine to select colonies that contained
the respective plasmids. Individual colonies were streaked on agar plates that
contained 0.75 mg/ml 5-fluoroorotic acid (5-FOA) to select for loss of the
respective URA3 plasmids. Mutations deemed insufficient for supporting cell
growthwere those that failed to yield 5-FOA-resistant colonies after incubation
for 10 days at 23C, 30C, or 37C. Viable strains were grown in YPAD broth to
an A600 of 0.6–0.8, adjusted to an A600 of 0.5 in 15% glycerol, and stored
at 80C. Each strain and the respective serial 10-fold dilutions (101, 102,
and 103) were spotted on YPAD agar plates. All the strains were scored after
growth at 23C, 30C, and 37C for 3–4 days.ACCESSION NUMBERS
Coordinates and native structure factors have been deposited in the Protein
Data Bank under ID code 3KYH.SUPPLEMENTAL INFORMATION
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